ABIONYX Pharma Provides an Update on Its Business and Cash Position for the Third Quarter of 2024
Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - eligible for PEA PME), a new generation biotech company dedicated to ...
Yahoo Finance1h
Activate Welcomes New Board Members and Announces Activate Fellows Have Reached a $3.5B Funding Milestone
BERKELEY, Calif., November 14, 2024--(BUSINESS WIRE)--Activate, the nonprofit fellowship where science entrepreneurs ...